Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

No Seismic Shifts As Torrential Rain Dampens JPM Jamboree

Jan 21 2018

• By Mike Ward

Related Content

Celgene's $1.1bn Impact Buy Is First Of More Deals To Come In 2018 And Beyond

Jan 09 2018

New Payment And Financing Models For Curative Regenerative Medicines

Jul 24 2017

In Vivo's 2017 Deals Of The Year: The Winners Are…

Jan 17 2018

Biopharma 2018: Is There Still A Place For Pharma In The New Health Care Economy?

Jan 29 2018

Related Companies

Spark Therapeutics, Inc.

Sanofi

Bristol Myers Squibb Company

Takeda Pharmaceutical Co. Ltd.

Alnylam Pharmaceuticals Inc.

Regeneron Pharmaceuticals, Inc.

Impact Biomedicines, Inc.

Teva Pharmaceutical Industries Ltd.

Alder Biopharmaceuticals, Inc.

Eli Lilly and Company

Amgen, Inc.

Atara Biotherapeutics, Inc.

NANO MRNA Co., Ltd.

Global Blood Therapeutics, Inc.

Ablynx N.V.

Novo Nordisk A/S

Sio Gene Therapies, Inc.

AbbVie Inc.

Johnson & Johnson

Actelion Pharmaceuticals Ltd.

Gilead Sciences, Inc.

Kite Pharma, Inc.

Additional Topics

Business Strategies Commercial Deals Market Intelligence BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window